Skip to main content
OpenTrials
Completed

NCT Number: NCT01866215

Effects of Exercise on Fructose Metabolism

A high fructose diet increases fasting and post-prandial triglyceride (TG) concentrations in sedentary healthy human subjects.These effects may be secondary to fructose-induced hepatic de novo lipogenesis. Recent evidence indicate that exercise can prevent fructose induced dyslipidemia.This study will evaluate

1. how exercise effects the metabolic fate of oral fructose 1a) when exercise is performed before fructose ingestion 1b) when exercise is performed after fructose ingestion Metabolic effects of exercise will be assessed in healthy male subjects by measuring fructose oxidation (13CO2 production), fructose conversion into glucose (13C glucose concentrations in blood) and hepatic fructose conversion into lipid (13C palmitate-very low density lipoprotein (VLDL) concentrations in blood) after ingestion of 13C-labelled fructose meals 2. how fructose and protein modulate muscle glycogen and intramyocellular lipid repletion after exercise Healthy male subjects will be fed various fructose, glucose, lipid and whey protein meals after a glycogen/intramyocellular lipid depleting exercise. The effects of meals' composition will be assessed after 24 hours by measuring intramyocellular lipids and glycogen using proton-magnetic resonance spectroscopy (MRS).

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Age range

18 year–40 year

Sex eligibility

Male

Study type

Interventional

Phase

Not applicable

Primary location

Centre Hospitalier Universitaire Vaudois

Lausanne, Canton of Vaud, CH-1011, Switzerland

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • males
  • 18-40 years old
  • 19 kg/m2>BMI>25kg/m2
  • moderate to high usual physical activity
  • non-smokers

Exclusion criteria

  • family history of diabetes mellitus
  • ECG anomaly
  • any medication
  • participation to blood spending or other clinical study in the 3 months before the beginning of this study
  • consumption of drugs
  • consumption of more than 50g alcool/week
  • family history of food intolerance

Treatment and study plan

Exercise

Other

cycling at 100W during 60 min

Fructose

Dietary Supplement

isocaloric nutrition with fructose, cream and whey protein during the 24 hour following a glycogen/intramyocellular lipid depleting exercise

Glucose

Dietary Supplement

isocaloric nutrition with glucose, cream and whey protein during the 24 hour following a glycogen/intramyocellular lipid depleting exercise

Primary outcomes

  1. Plasma triglyceride

    Time frame: measurements in fasting conditions and every hour from 7:00 am to 4:00 pm (up to 9 hours)

    measurement of total and VLDL-TG concentrations in study 1

  2. intramyocellular lipids

    Time frame: after glycogen/intramyocellular lipid depleting exercise and after 24 hour controlled feeding post exercise

    Measurement by 1H-MRS in muscle vastus lateralis in study 2

  3. Fructose conversion into lipids

    Time frame: measured from 7:00 am to 4:00 pm in study 1 (up to 9 hours)

    Estimated from 13C palmitate-VLDL concentration

Secondary outcomes

  1. Fructose conversion into glucose

    Time frame: measured between 7:00 am and 4:oo pm (up to 9 hours)

    measurements obtained from plasma 13C glucose concentrations and whole body glucose production measured by 6,6 d2 glucose in study 1)

  2. intramyocellular glycogen concentrations

    Time frame: after glycogen/intramyocellular lipid depleting exercise and after 24 hour controlled feeding post exercise

    Measured by 1H-MRS in muscle vastus lateralis in study 2

  3. fructose oxidation

    Time frame: measured from 7:00 am to 4:00 pm in study 1 (up to 9 hours)

    Calculated from breath 13CO2 production

  4. exogenous lipid oxidation

    Time frame: measured from 7:00 am to 4:00 pm in study 2 (up to 9 hours)

    Lipids ingested will be labeled with 13C-triolein, and exogenous lipid oxidation will be measured from breath 13CO2 production

Sponsors and collaborators

Lead sponsor

University of Lausanne

Other

Collaborators

  • Centre Hospitalier Universitaire Vaudois
  • University of Bern

Registry information

Acronym: FruEx2

Important dates

Study start
2013
Primary completion
2014
Study completion
2014
First posted
May 31, 2013
Registry last updated
Jun 4, 2014

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.